Skip to content

Clinical Study on Endometrial Receptivity

Clinical Study on the Impact of Route of Administration of Progesterone and Endometriosis on Endometrial Receptivity

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03687021
Enrollment
35
Registered
2018-09-27
Start date
2018-10-10
Completion date
2018-11-10
Last updated
2018-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Receptivity;RNA; Progesterone

Keywords

endometrial receptivity, RNA, progesterone

Brief summary

to explore the differential expression of miRNA in the implantation window of patients with endometriosis and the time of progesterone and route of administration on planting window

Interventions

DRUGProgesterone

Different routes of administration of progesterone; Whether there is endometriosis

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. The endometriosis group treatment group: Previous laparoscopy or laparotomy confirmed endometriosis;Regular menstruation, no rule vaginal bleeding;Ovarian reserve function is normal. control group: Laparoscopic bilateral salpingectomy was performed due to ectopic pregnancy, benign ovarian changes and other reasons, with the exception of endometriosis during the operation.Regular menstruation, no rule vaginal bleeding;Ovarian reserve function is normal 2. progesterone group Women with hypothalamic amenorrhea or premature ovarian failure;Ages 18-40

Exclusion criteria

Patients with medical complications

Design outcomes

Primary

MeasureTime frameDescription
endometrial receptivity measured by pathology3 months35 samples will be measured.

Secondary

MeasureTime frameDescription
endometrial receptivity measured by immunohisochemistry3 months35 samples will be measured
endometrial receptivity measured by Ribose Nucleic Acid (RNA)3 months35 samples will be measured
endometrial receptivity measured by scanning electron microscope3 months35 samples will be measured

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026